Related Experiment Video

Updated: Mar 25, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K

Therapeutic vaccines for prostate cancer: recent advances and future directions

Julius Strauss1, Ravi A Madan1

  • 1a Genitourinary Malignancies Branch, Center for Cancer Research , National Cancer Institute , Bethesda , MD , USA.

Expert Review of Vaccines
|February 19, 2016
PubMed

Insights

Therapeutic cancer vaccines show promise for prostate cancer, especially in earlier stages. Combinations with traditional therapies and immune checkpoint inhibitors are being explored in ongoing clinical trials.

Area of Science:

  • Oncology
  • Immunology
  • Urology

Background:

  • Therapeutic cancer vaccines are emerging as a promising treatment modality for prostate cancer.
  • Several vaccine platforms are currently undergoing Phase III trials for prostate cancer treatment.
  • Evidence suggests vaccine efficacy is higher in patients with indolent or earlier-stage disease.

Purpose of the Study:

  • To review the current landscape of therapeutic cancer vaccines in prostate cancer.
  • To explore the potential synergy between vaccine therapies and traditional prostate cancer treatments.
  • To discuss ongoing clinical trials investigating vaccines in early-stage disease and in combination with other therapies.

Main Methods:

  • Review of recent clinical trial data and preclinical studies on prostate cancer vaccines.
  • Analysis of combination strategies involving vaccines with anti-androgens, cytotoxic therapy, radiation, and immune checkpoint inhibitors.
  • Evaluation of preliminary data from ongoing clinical trials in early-stage prostate cancer.

Main Results:

  • Therapeutic cancer vaccines are a viable option for prostate cancer treatment.
  • Combination therapies, including with traditional treatments and immune checkpoint inhibitors, show promise.
  • Early-stage disease and indolent cancer may benefit most from vaccine therapies.

Conclusions:

  • Therapeutic cancer vaccines represent a significant advancement in prostate cancer immunotherapy.
  • Combining vaccines with established treatments and novel immunotherapies is a key area of ongoing research.
  • Future directions point towards optimized immune responses and improved patient outcomes through combination strategies.
Keywords:
ImmunotherapyProstate CancerVaccines

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.8K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
41